These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 17532197

  • 1. Effects of TNFalpha on the human nasal mucosa in vivo.
    Widegren H, Korsgren M, Andersson M, Greiff L.
    Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P, Tillie-Leblond I, Malaquin F, Durieu J, Wallaert B, Tonnel AB.
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [Abstract] [Full Text] [Related]

  • 3. Effects of intranasal TNFalpha on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis.
    Widegren H, Erjefält J, Korsgren M, Andersson M, Greiff L.
    Respir Res; 2008 Jan 30; 9(1):15. PubMed ID: 18234086
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of Clara cell 10 (CC10) protein on symptoms and signs of allergic rhinitis.
    Widegren H, Andersson M, Greiff L.
    Ann Allergy Asthma Immunol; 2009 Jan 30; 102(1):51-6. PubMed ID: 19205286
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
    Ciprandi G, Tosca MA, Passalacqua G, Canonica GW.
    Ann Allergy Asthma Immunol; 2001 Apr 30; 86(4):433-8. PubMed ID: 11345288
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
    Greiff L, Persson CG, Andersson M.
    Ann Allergy Asthma Immunol; 2002 Oct 30; 89(4):413-8. PubMed ID: 12392387
    [Abstract] [Full Text] [Related]

  • 11. Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis.
    Meyer P, Andersson M, Persson CG, Greiff L.
    Pediatr Allergy Immunol; 2003 Feb 30; 14(1):60-5. PubMed ID: 12603713
    [Abstract] [Full Text] [Related]

  • 12. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM, Mucha SM, Detineo M, Naclerio RM.
    J Allergy Clin Immunol; 2008 May 30; 121(5):1126-1132.e7. PubMed ID: 18367240
    [Abstract] [Full Text] [Related]

  • 13. [Myeloperoxidase (MPO) as a marker of neutrophil influx into nasal mucosa after recombinant IL-8 challenge].
    Kupczyk M, Bocheńska-Marciniak M, Górski P, Kuna P.
    Pneumonol Alergol Pol; 2002 May 30; 70(11-12):544-9. PubMed ID: 12884563
    [Abstract] [Full Text] [Related]

  • 14. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
    Greiff L, Petersen H, Mattsson E, Andersson M, Erjefält JS, Linden M, Svensson C, Persson CG.
    Clin Exp Allergy; 2001 Aug 30; 31(8):1321-7. PubMed ID: 11529904
    [Abstract] [Full Text] [Related]

  • 15. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
    Greiff L, Andersson M, Svensson C, Persson CG.
    Clin Exp Allergy; 1997 Apr 30; 27(4):438-44. PubMed ID: 9146938
    [Abstract] [Full Text] [Related]

  • 16. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
    Erin EM, Zacharasiewicz AS, Nicholson GC, Tan AJ, Higgins LA, Williams TJ, Murdoch RD, Durham SR, Barnes PJ, Hansel TT.
    Clin Exp Allergy; 2005 Dec 30; 35(12):1608-14. PubMed ID: 16393327
    [Abstract] [Full Text] [Related]

  • 17. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M, Neukirch C, Grandsaigne M, Leçon-Malas V, Ravaud P, Dehoux M, Aubier M.
    Allergy; 2006 Jan 30; 61(1):111-8. PubMed ID: 16364165
    [Abstract] [Full Text] [Related]

  • 18. Effects of topical formoterol alone and in combination with budesonide in a pollen season model of allergic rhinitis.
    Ahlström Emanuelsson C, Andersson M, Persson CG, Thorsson L, Greiff L.
    Respir Med; 2007 Jun 30; 101(6):1106-12. PubMed ID: 17215115
    [Abstract] [Full Text] [Related]

  • 19. Allergen challenge-induced acute exudation of IL-8, ECP and alpha2-macroglobulin in human rhinovirus-induced common colds.
    Greiff L, Andersson M, Svensson C, Linden M, Myint S, Persson CG.
    Eur Respir J; 1999 Jan 30; 13(1):41-7. PubMed ID: 10836321
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor in allergen-induced nasal inflammation.
    Choi GS, Park HJ, Hur GY, Choi SJ, Shin SY, Ye YM, Park HS.
    Clin Exp Allergy; 2009 May 30; 39(5):655-61. PubMed ID: 19236408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.